Loading...
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Randomised Controlled Trial
PURPOSE: Patients with cognitive impairment (CI) are at high risk of fracture but often denied osteoporosis therapy. We tested whether the effects of zoledronic acid (Zol) on re-fracture and mortality differed in patients presenting with a hip fracture by cognitive status. METHODS: We used data from...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3867338/ https://ncbi.nlm.nih.gov/pubmed/23812596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-013-2420-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|